Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01963780 · ClinicalTrials.gov registry record · NA
International EXPAND Lung Pivotal Trial
A NA study, sponsored by TransMedics.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT01963780 is a NA study that has completed, run by TransMedics. The registered enrollment target is 79 participants.
The verdict
NCT01963780, a NA study, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.
Interventions
- DEVICE OCS Lung Preservation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2013-11 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01963780
The ClinicalTrials.gov registry entry for NCT01963780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OCS Lung Preservation is the first listed.
NCT01963780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01963780 about?
NCT01963780 is a clinical study titled "International EXPAND Lung Pivotal Trial". To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.
What is the current status of trial NCT01963780?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2013-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01963780?
The interventions under investigation include: OCS Lung Preservation (DEVICE).
Who is sponsoring clinical trial NCT01963780?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.